STERIS plc
STE
Clasificación en acciones
#1070
STERIS plc provides infection prevention products and services in the United... STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Precio por acción
$222.31
Última sincronización: 2026-10-19
Capitalización bursátil
$21.68B
Cambio (1 día)
0.06%
Cambio (1 año)
-8.22%
País
IE
Comercio STERIS plc (STE)
Categoría
Healthcare
Ratio P/E de STERIS plc (STE)
Ratio P/E al October 2026 TTM: 26.50
Según los últimos informes financieros y el precio de las acciones de STERIS plc, el P/E actual (TTM) de la empresa es 26.50. Al final de 2024, la empresa tenía un P/E de 57.73.
Historial del ratio P/E de STERIS plc desde 2000 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 26.50 | -27.11% |
| 2025 | 36.35 | -37.03% |
| 2024 | 57.73 | -67.60% |
| 2023 | 178.19 | 84.29% |
| 2022 | 96.69 | 136.75% |
| 2021 | 40.84 | 40.30% |
| 2020 | 29.11 | -17.88% |
| 2019 | 35.45 | 29.90% |
| 2018 | 27.29 | -49.46% |
| 2017 | 53.99 | 19.05% |
| 2016 | 45.35 | 46.71% |
| 2015 | 30.91 | 42.11% |
| 2014 | 21.75 | 45.00% |
| 2013 | 15.00 | 10.64% |
| 2012 | 13.56 | -66.07% |
| 2011 | 39.96 | 159.24% |
| 2010 | 15.41 | 24.68% |
| 2009 | 12.36 | -43.79% |
| 2008 | 21.99 | 4.33% |
| 2007 | 21.08 | -12.03% |
| 2006 | 23.96 | 17.67% |
| 2005 | 20.36 | 7.34% |
| 2004 | 18.97 | -17.33% |
| 2003 | 22.95 | -27.34% |
| 2002 | 31.58 | -95.52% |
| 2001 | 705.00 | 1,000.49% |
| 2000 | 64.06 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| - | - |
DE
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.